Sai Parenteral’s IPO Receives 4% Subscription on First Day
New Delhi, March 24 – The initial public offering (IPO) of Sai Parenteral’s Ltd, a diversified pharmaceutical formulation company, received a 4% subscription on Tuesday, the first day of bidding.Initial Bidding Figures
According to...
capital markets
contractdevelopmentandmanufacturingorganization
equity shares
global formulations
india
initial public offering
injectable products
investment
ipo subscription
new delhi
oral solid dosage formulations
pharmaceutical formulation
price band
public offering
sai parenteral
